COMPASS Pathways (CMPS) Stock Chart & Stock Price History → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free CMPS Stock Alerts $7.91 +0.07 (+0.89%) (As of 02:58 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media COMPASS Pathways Stock Price Performance5 Day Performance-5.31%1 Month Performance-6.44%3 Month Performance-22.91%6 Month Performance+29.59%Year-To-Date Performance-10.40%1 Year Performance-2.73% Receive CMPS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for COMPASS Pathways and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry CMPS Stock Chart for Monday, May, 20, 2024 CMPS Chart by TradingView COMPASS Pathways Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$7.99$7.84-1.88%$8.19$7.71335,869 shs$536.10 million05/16/2024$8.28$7.99-3.50%$8.39$7.99244,582 shs$546.36 million05/15/2024$8.17$8.28+1.35%$8.42$8.17208,959 shs$566.19 million05/14/2024$8.12$8.17+0.62%$8.47$8.14261,980 shs$558.67 million05/13/2024$7.86$8.12+3.31%$8.20$8.00227,448 shs$555.25 million05/10/2024$8.54$7.86-7.96%$8.79$7.84622,753 shs$486.85 million Get the Latest News and Ratings for CMPS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for COMPASS Pathways and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$8.50$8.54+0.47%$8.87$8.21365,346 shs$528.97 million05/08/2024$8.54$8.50-0.47%$9.63$8.20808,145 shs$526.49 million05/07/2024$8.61$8.54-0.81%$8.68$8.24484,004 shs$528.97 million05/06/2024$8.53$8.61+0.94%$8.84$8.56189,012 shs$533.30 million05/03/2024$8.25$8.53+3.39%$9.36$8.47519,862 shs$528.35 million05/02/2024$8.48$8.25-2.71%$8.78$8.18244,407 shs$511.01 million05/01/2024$8.57$8.48-1.05%$8.85$8.33282,617 shs$525.25 million04/30/2024$8.11$8.57+5.67%$8.60$7.89317,669 shs$530.83 million04/29/2024$7.94$8.11+2.14%$8.23$7.86241,767 shs$502.33 million04/26/2024$7.86$7.94+1.02%$8.07$7.78258,412 shs$491.80 million04/25/2024$8.10$7.86-2.96%$8.10$7.641.49 million shs$486.85 million04/24/2024$8.25$8.10-1.82%$8.38$7.89887,694 shs$501.71 million04/23/2024$8.36$8.25-1.32%$8.65$8.21354,981 shs$511.01 million04/22/2024$8.38$8.36-0.24%$8.49$8.19363,289 shs$517.82 million04/19/2024$8.42$8.38-0.48%$8.70$8.23369,848 shs$519.06 million04/18/2024$8.53$8.42-1.29%$8.69$8.31291,553 shs$521.54 million04/17/2024$8.78$8.53-2.85%$8.90$8.51322,606 shs$528.37 million04/16/2024$8.32$8.78+5.53%$8.86$8.17528,916 shs$543.83 million04/15/2024$8.66$8.32-3.93%$8.84$8.20539,174 shs$515.34 million04/12/2024$9.18$8.66-5.66%$9.22$8.60465,856 shs$536.43 million04/11/2024$9.17$9.18+0.11%$9.32$9.02461,966 shs$568.61 million04/10/2024$9.57$9.17-4.18%$9.45$9.00278,851 shs$567.99 million04/09/2024$9.74$9.57-1.75%$9.80$9.51355,716 shs$592.77 million04/08/2024$9.50$9.74+2.53%$9.97$9.36559,627 shs$603.30 million04/05/2024$9.80$9.50-3.06%$9.80$9.16842,567 shs$588.05 million04/04/2024$9.70$9.80+1.03%$10.31$9.79764,726 shs$606.62 million04/03/2024$9.45$9.70+2.65%$10.03$9.32816,652 shs$600.43 million04/02/2024$9.68$9.45-2.38%$9.49$8.62663,627 shs$585.33 million04/01/2024$8.32$9.68+16.35%$9.70$8.591.12 million shs$599.58 million03/29/2024$8.32$8.32$9.35$8.123.56 million shs$515.34 million03/28/2024$9.50$8.32-12.42%$9.35$8.123.56 million shs$515.34 million03/27/2024$9.31$9.50+2.04%$9.60$9.22232,681 shs$588.43 million03/26/2024$9.17$9.31+1.53%$9.50$9.20332,360 shs$576.66 million03/25/2024$8.98$9.17+2.12%$9.37$8.95274,361 shs$567.99 million**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report03/22/2024$9.50$8.98-5.47%$9.48$8.91574,727 shs$556.22 million03/21/2024$9.78$9.50-2.86%$10.01$9.30335,299 shs$588.43 million03/20/2024$9.53$9.78+2.62%$9.93$9.40273,904 shs$605.77 million03/19/2024$9.79$9.53-2.66%$9.87$9.44351,837 shs$590.29 million03/18/2024$9.90$9.79-1.11%$9.97$9.16604,985 shs$606.00 million03/15/2024$9.80$9.90+1.07%$9.98$9.74376,177 shs$612.81 million03/14/2024$10.66$9.80-8.11%$10.64$9.68731,894 shs$606.28 million03/13/2024$10.76$10.66-0.88%$11.18$10.58458,439 shs$659.82 million03/12/2024$10.67$10.76+0.80%$10.79$10.33333,030 shs$665.73 million03/11/2024$10.88$10.67-1.93%$11.32$10.62714,188 shs$660.47 million03/08/2024$11.28$10.88-3.55%$11.57$10.531.43 million shs$673.47 million03/07/2024$10.91$11.28+3.39%$11.72$10.871.52 million shs$698.23 million03/06/2024$10.87$10.91+0.37%$11.58$10.87511,115 shs$675.33 million03/05/2024$11.50$10.87-5.48%$11.90$10.76727,779 shs$698.18 million03/04/2024$11.48$11.50+0.17%$12.57$11.34806,783 shs$738.65 million03/01/2024$10.27$11.48+11.78%$11.92$10.211.04 million shs$710.38 million02/29/2024$12.37$10.27-16.98%$12.00$9.802.05 million shs$635.51 million02/28/2024$11.71$12.37+5.64%$12.75$11.34964,781 shs$765.46 million02/27/2024$10.68$11.71+9.64%$11.94$10.96746,893 shs$724.62 million02/26/2024$10.19$10.68+4.81%$10.74$10.13504,828 shs$660.88 million02/23/2024$10.01$10.19+1.80%$10.26$9.75264,932 shs$630.56 million02/22/2024$9.92$10.01+0.91%$10.11$9.63287,660 shs$619.42 million02/21/2024$10.17$9.92-2.46%$10.10$9.56786,957 shs$613.85 million02/20/2024$10.51$10.17-3.24%$11.32$9.901.26 million shs$629.32 million02/19/2024$10.51$10.51$10.73$10.43309,800 shs$650.36 million Related Companies: ABUS Stock Chart LRMR Stock Chart VERV Stock Chart ALT Stock Chart KALV Stock Chart TVTX Stock Chart OCS Stock Chart STTK Stock Chart ATXS Stock Chart APLT Stock Chart Receive CMPS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for COMPASS Pathways and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CMPS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsUrgent Nvidia WarningAltimetryThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding COMPASS Pathways plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.